Personal View: Low-Dose Lung Radiotherapy Should be Evaluated as a Treatment for Severe COVID-19 Lung Disease
Clin Oncol (R Coll Radiol)
.
2021 Jan;33(1):e64-e68.
doi: 10.1016/j.clon.2020.08.003.
Epub 2020 Aug 14.
Authors
D Hadjiyiannakis
1
,
D Dimitroyannis
2
,
L Eastlake
3
,
C Peedell
4
,
L Tripathi
1
,
R Simcock
5
,
A Vyas
6
,
E Deutsch
7
,
A J Chalmers
8
Affiliations
1
Lancashire Teaching Hospitals, NHS Foundation Trust, Preston, UK; NIHR Lancashire Clinical Research Facility, Preston, UK.
2
Edward Hines Jr, VA Hospital, Hines, Illinois, USA.
3
University Hospitals Plymouth NHS Trust, Plymouth, UK. Electronic address:
[email protected]
.
4
James Cook University Hospital, Middlesbrough, UK.
5
Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
6
Lancashire Teaching Hospitals, NHS Foundation Trust, Preston, UK.
7
Radiation Oncology Department, Gustave Roussy Cancer Campus, Université Paris, Villejuif, France.
8
Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
PMID:
32829986
PMCID:
PMC7427522
DOI:
10.1016/j.clon.2020.08.003
No abstract available
Publication types
Editorial
Research Support, Non-U.S. Gov't